| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 2025 | Oct 21, 2025 | MBX Biosciences, Inc. | CEO | Buy | 85.0 | +20,000 | 2.15% | ✗ | $272.8K |
| Feb 4, 2025 | Feb 5, 2025 | MBX Biosciences, Inc. | CEO | Buy | 92.5 | +50,000 | 5.68% | ✗ | $534.5K |
| Mar 10, 2017 | Mar 14, 2017 | MetaVia Inc. | Director | Buy | 95.0 | +25,000 | 28.11% | ✗ | $236.8K |
| Aug 10, 2016 | Aug 12, 2016 | MetaVia Inc. | Director | Buy | 97.5 | +25,816 | 36.15% | ✗ | $255.5K |